Health Care Providers’ Perspectives on Barriers and Facilitators to Cervical Cancer Screening in Vietnamese American Women

2017 ◽  
Vol 29 (5) ◽  
pp. 441-448 ◽  
Author(s):  
Connie Kim Yen Nguyen-Truong ◽  
Dena Hassouneh ◽  
Frances Lee-Lin ◽  
Chiao-Yun Hsiao ◽  
Tuong Vy Le ◽  
...  
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Health Care Providers ◽  
Barriers And Facilitators ◽  
Cultural Barriers ◽  
Care Providers ◽  
American Women ◽  
Vietnamese American ◽  
Health Care Practices ◽  
Hispanic American Women

Introduction: Vietnamese American women (VAW) are diagnosed and die at twice the rate than White non-Hispanic American women (16.8/100,000 vs. 8.1/100,000 and 4.4/100,000 vs. 2.4/100,000, respectively). Despite efforts to increase cervical cancer (CC) screening among VAW, the participation rates are persistently low (69% to 81%). The purpose of this study was to explore health care providers’ (HCPs) perspectives on barriers and facilitators to CC screening in VAW. Method: This qualitative descriptive pilot study, used open-ended semistructured interviews with 10 HCPs. Results: The HCPs had two to 23 years treating VAW. Major barriers and facilitators identified by the HCPs were as follows: VAW’s decision making about CC screening; sexual health divide; language discordance, relying on interpreters; breaking suspicion; VAW’s exposure to health sources of CC screening; sustainable trust; and motivated health care practices. Discussion: HCPs perceived the reasons for VAW not being screened or delaying CC screening were due to their lack of knowledge, cultural barriers, language, and issues related to trust.

scholarly journals Needs Assessment of Barriers to Cervical Cancer Screening in Vietnamese American Health Care Providers

2006 ◽  
Vol 4 (3) ◽  
pp. 146-156 ◽  
Author(s):  
Harry T. Kwon ◽  
Felicia M. Solomon ◽  
Si Nguyen
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Needs Assessment ◽  
Health Care Providers ◽  
Pap Test ◽  
The United States ◽  
Care Providers ◽  
Pap Tests ◽  
Vietnamese American ◽  
Vietnamese Women

Vietnamese women living in the United States have a cervical cancer incidence rate that is five times that of White women. The low rate of cervical cancer screening among this high-risk population contributes to this disparity. In 2004, the National Cancer Institute collaborated with the Vietnamese American Medical Association to conduct a short needs assessment questionnaire (Pap Test Barriers Questionnaire for Health Care Providers) among its members to assess provider views about cervical cancer, barriers to Pap testing among Vietnamese women living in the United States, and types of patient education materials needed to help motivate Vietnamese women to receive a Pap test. Information from the questionnaire was used to inform development of a brochure and identify additional strategies to enhance outreach to Vietnamese women and providers. Almost all of the respondents (95%) thought that Pap tests were “very important” in the early detection of cervical cancer in Vietnamese women. In addition, knowledge about the importance of Pap tests was identified as the most influential factor for Vietnamese women not seeking a Pap test. Print materials that included both English and Vietnamese translations in the same publication were cited as a preferred communication tool. Further, health education through Vietnamese media was recommended as a primary strategy for reaching women with educational messages. Findings from this needs assessment contributes to a larger formative research effort to build NCI’s cervical cancer education program within its Office of Education and Special Initiatives.

scholarly journals Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer

2012 ◽  
Vol 29 (4) ◽  
pp. 213-218
Author(s):  
F Hussain ◽  
MS Flora ◽  
K Nahar ◽  
M Khan
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Cancer Prevention ◽  
Health Care Providers ◽  
Hpv Vaccination ◽  
Cervical Cancer Prevention ◽  
Care Providers ◽  
Before And After ◽  
Post Test ◽  
Cancer Prevention Program

Background: The field of cervical cancer prevention is  rapidly evolving because of identification of Human  Papilloma Virus (HPV) as the necessary cause of disease.  HPV vaccines are now in the market. For successful  triggering of cervical cancer prevention program, HPV  informations should be communicated to health care  providers whose understanding about HPV has lagged  behind the scientific and technical advances.Objective: The objective of this intervention study was to  identify gap and educate health care providers delivering  services to women and adolescents in Medical Colleges on  HPV related issues and vaccination.Methods: The study was done from July 2007 to June 2008  where 3 advocacy workshops were conducted. The  knowledge level of 106 participants were assessed before  and after intervention. Updated informations about HPV  and vaccine was given to participants as intervention.Results: Wide knowledge gap was identified among  participants on HPV related insues, but significant  improvement was observed following intervention. The  pretest and post test score of knowledge was 28.09 and 38.60  respectively showing an average increase of 10 after  intervention.Conclusions: HPV education should be extensively  disseminated to health care providers to obtain public health  benefits of HPV vaccination program. DOI: http://dx.doi.org/10.3329/jbcps.v29i4.11329 J Bangladesh Coll Phys Surg 2011; 29: 213-218

scholarly journals Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.

2016 ◽  
Vol 34 (3_suppl) ◽  
pp. 155-155
Author(s):  
Cleo A. Samuel ◽  
Kea Turner ◽  
Heidi AS Donovan ◽  
G J. Van Londen
Keyword(s):  
Health Care ◽  
Endocrine Therapy ◽  
Health Care Providers ◽  
Symptom Management ◽  
Adjuvant Endocrine Therapy ◽  
Barriers And Facilitators ◽  
System Level ◽  
Care Providers ◽  
Provider Perspectives ◽  
Related Symptom

155 Background: Adjuvant endocrine therapy (AET)-related symptom management (SM) among breast cancer survivors (BCS) typically involves a multidisciplinary team of health care providers; yet few studies have examined provider perspectives on AET-related SM. The purpose of this study was to examine provider perspectives on the barriers and facilitators to AET-related SM among BCS and opportunities for improvement. Methods: We conducted 3 focus groups (FGs) with a multidisciplinary group of health care providers (n = [6] physician; n = [7] non-physician) experienced in caring for BCS undergoing AET. We utilized semi-structured discussion guides to elicit provider perspectives on AET-related SM and its barriers and facilitators as well as recommendations for improvement. All FGs were held at the University of Pittsburgh, audiotaped, and transcribed. We analyzed FG transcripts using qualitative software to identify key themes. Results: Providers described patient-, provider-, and system- level facilitators and barriers to AET-related SM. At the patient-level, facilitators included social support and provider communication about symptoms while cancer-related distress, misinformation and misinterpretation of online information were identified as barriers. Provider-level facilitators included strong relationships with other providers and ongoing communication with patients; however, lack of time, insufficient resources, and challenges distinguishing AET-related symptoms from other conditions were key provider-level barriers. Finally, at the system-level, electronic health records were described as both a facilitator and barrier to SM. Moreover, poor care coordination among different providers and lack of clear guidelines on which provider “owns” AET-related SM emerged as key system-level barriers. Conclusions: Findings suggest that efforts to improve AET-related SM should span multiple levels, in order to address patient-, provider-, and system-level barriers to SM. Recommendations include increased education for patients, greater access to clinical decision support tools for providers, and improved coordination of survivorship resources within hospitals.

scholarly journals Awareness about human papilloma virus vaccine among medical students

2016 ◽  
Vol 7 (4) ◽  
pp. 64-67 ◽  
Author(s):  
Snigdha Kamini ◽  
Devi Madhavi Bhimarasetty
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Medical Students ◽  
Human Papilloma Virus ◽  
Health Care Providers ◽  
Hpv Vaccination ◽  
Human Papilloma Virus Vaccine ◽  
Care Providers ◽  
Papilloma Virus ◽  
Medical College

Background: Human papilloma virus is a causative agent of cervical cancer. Hence,vaccination against HPV is an important mode of primary prevention against cervical cancer. Two vaccines against HPV have been approved and recommended for use in India. However the availability of these vaccines is hardly known and seldom utilised even among the medical fraternity.Aims and Objectives: This study aims to find out the awareness about HPV vaccination among medical students of Andhra Medical College, India. Results of this study will help in assessing the need for awareness programs among health care professionals regarding this important public health issue. Materials and Methods: An observational descriptive study was conducted to know the awareness of HPV infection and vaccination among medical students of a government medical college at Visakhapatnam in Andhra Pradesh. A pretested questionnaire was administered to students of final MBBS Part 1 and final MBBS part 2. Results were analyzed in MS excel and the statistical significance of difference in knowledge between males and females was assessed. Results: Overall, the level of awareness reported was 54.5%. Females had slightly better knowledge than males. Students of final year Part 2 had better knowledge the Final year part 1. The most commonly cited source of information was medical education and the most important factor that deterred subjects from receiving/advising HPV vaccination was lack of knowledge. Conclusion: There exists a large gap in knowledge regarding HPV vaccination. Addressing this gap is necessary if we want to decrease the burden of cervical cancer in India. Medical students, health care providers should be sensitized first and then we should reach out to the public.Asian Journal of Medical Sciences Vol.7(4) 2016 64-67

Barriers and Facilitators to Testing in Primary Care Among Health Care Providers

2011 ◽  
Vol 103 (5) ◽  
pp. 432-438 ◽  
Author(s):  
Emma M. Simmons ◽  
Monique J. Brown ◽  
Kay Slye ◽  
Mindy Ma ◽  
Madeline Y. Sutton ◽  
...  
Keyword(s):  
Primary Care ◽  
Health Care ◽  
Health Care Providers ◽  
Barriers And Facilitators ◽  
Care Providers

scholarly journals Exploring Healthcare Professionals' Use of Narrative Mediation Approaches to Address Disclosure and Apology in the Aftermath of Medical Errors

2016 ◽  
Vol 3 (1) ◽  
pp. 24
Author(s):  
Gerald Monk ◽  
Stacey Sinclair ◽  
Michael Nelson
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Medical Errors ◽  
Narrative Analysis ◽  
Health Care Professionals ◽  
Health Care Systems ◽  
The United States ◽  
Cultural Barriers ◽  
Care Providers ◽  
Care Systems

Despite the overwhelming evidence that suggests that patients, families and health care systems benefit from offering appropriate disclosures and apologies to patients and families following the aftermath of medical errors, few health care organizations in the U.S. invest in providing systemic training in disclosure and apology. Using a narrative analysis this paper explores the cultural barriers in the United States healthcare environment that impede health care providers from engaging in restorative conversations with patients and families when things go wrong. The paper identifies a handful of programs and models that provide disclosure and apology training and argues for the unique contributions of narrative mediation to assist health care professionals to disclose adverse events to patients and families to restore trust.

scholarly journals Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline

2016 ◽  
Vol 2 (5) ◽  
pp. 311-340 ◽  
Author(s):  
Linus T. Chuang ◽  
Sarah Temin ◽  
Rolando Camacho ◽  
Alfonso Dueñas-Gonzalez ◽  
Sarah Feldman ◽  
...  
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Palliative Care ◽  
Radiation Therapy ◽  
Health Care Providers ◽  
Invasive Cervical Cancer ◽  
Treatment Guideline ◽  
Evidence Based ◽  
Care Providers ◽  
Fertility Sparing

Purpose To provide evidence-based, resource-stratified global recommendations to clinicians and policymakers on the management and palliative care of women diagnosed with invasive cervical cancer. Methods ASCO convened a multidisciplinary, multinational panel of cancer control, medical and radiation oncology, health economic, obstetric and gynecologic, and palliative care experts to produce recommendations reflecting resource-tiered settings. A systematic review of literature from 1966 to 2015 failed to yield sufficiently strong quality evidence to support basic- and limited-resource setting recommendations; a formal consensus-based process was used to develop recommendations. A modified ADAPTE process was also used to adapt recommendations from existing guidelines. Results Five existing sets of guidelines were identified and reviewed, and adapted recommendations form the evidence base. Eight systematic reviews, along with cost-effectiveness analyses, provided indirect evidence to inform the consensus process, which resulted in agreement of 75% or greater. Recommendations Clinicians and planners should strive to provide access to the most effective evidence-based antitumor and palliative care interventions. If a woman cannot access these within her own or neighboring country or region, she may need to be treated with lower-tier modalities, depending on capacity and resources for surgery, chemotherapy, radiation therapy, and supportive and palliative care. For women with early-stage cervical cancer in basic settings, cone biopsy or extrafascial hysterectomy may be performed. Fertility-sparing procedures or modified radical or radical hysterectomy may be additional options in nonbasic settings. Combinations of surgery, chemotherapy, and radiation therapy (including brachytherapy) should be used for women with stage IB to IVA disease, depending on available resources. Pain control is a vital component of palliative care. Additional information is available at www.asco.org/rs-cervical-cancer-treatment-guideline and www.asco.org/guidelineswiki . It is the view of ASCO that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines.

Sign in / Sign up

Export Citation Format

Share Document